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Staphylococcus aureus is the primary cause of a wide range 
of human infections, including septicaemia, abscesses and 
endocarditis (Lowy 1998). Although the rates of methi-
cillin-resistant S. aureus (MRSA) are declining in certain 
European hospitals, a recent study showed that the inci-
dence of MRSA bacteraemia was greater than 25 % in over 
one-third of European countries (Johnson 2011). In the 
United States, the rate of MRSA infection has decreased 
since 2006 (Klein et al. 2007); however, the proportion of 
those infections caused by the highly virulent, sequence 
type 8, USA300 clone has risen sharply (Jarvis et al. 2012; 
Rhee et al. 2015). USA300 is the predominant clone caus-
ing community-acquired infections in otherwise healthy 
individuals, and is now considered endemic in many US 
communities and hospitals (David and Daum 2010; Rhee 
et al. 2015). Even with increased surveillance, improved 
patient management and treatment regimes, S. aureus 
remains a major public health concern (Johnson 2011; 
Jarvis et al. 2012). As a response to the severe threat S. 
aureus possesses to global human health, a deeper under-
standing of its pathogenesis at the genetic and molecular 
level is warranted.
Staphylococcus aureus is both a major human pathogen 
and resident of the normal microflora. For decades, it has 
been considered an opportunistic pathogen, where breaches 
in host immunity are considered the route through which it 
transitions from being a coloniser to an invasive pathogen. 
This suggests that disease onset and severity are wholly 
driven by the host, where given identical opportunity two 
genetically distinct S. aureus isolates will cause identical 
disease. However, the fact that we have globally successful 
clones of S. aureus circulating and hyper-virulent strains 
causing a significant burden of disease suggests that spe-
cific bacterial features contribute significantly to the onset 
and severity of disease. Until we understand the effect of 
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these on disease in humans we will not have a full picture 
of this microbe’s pathogenicity.
Staphylococcus aureus possesses an extensive repertoire 
of virulence factors facilitating its dual life-style as a com-
mensal and a pathogen (Foster and Hook 1998; Vandenesch 
et al. 2012; Vorkapic et al. 2015), where the secretion of 
toxins is classically considered an essential element in the 
development of infection (Dinges et al. 2000). The staphy-
lococcal scientific literature is abundant with many excel-
lent studies involving the mechanism of action, host recep-
tor tropism and regulation of the many toxins secreted by S. 
aureus (Vandenesch et al. 2012; Ibarra et al. 2013; DuMont 
and Torres 2014). At present, we are at a stage where it is 
affordable to rapidly and accurately sequence large num-
bers of clinical isolates, resulting in new opportunities to 
study pathogen evolution, epidemiology and antibiotic 
resistance (Didelot et al. 2012). The question that has been 
presented is whether this revolution in next-generation 
sequencing and abundance in genomic information can aid 
in our understanding of the fundamental basis of S. aureus 
virulence.
As the secretion of toxins is an integral part of the S. 
aureus virulence repertoire, we focussed on investigating 
the molecular and genetic basis of toxin secretion. Here, 
we combined whole-genome sequencing and phenotypic 
data, developing a genome-wide association study (GWAS) 
to detail how polymorphisms affect bacterial cytotoxicity. 
In two recent publications, we document the functional 
genomics approach we undertook to determine which 
mutations affected this phenotype. In our first paper ‘Pre-
dicting the virulence of MRSA from its genome sequence’ 
(Laabei et al. 2014), we explored the use of GWAS to 
identify genes, acting singularly or in epistasis, which we 
predicted to have an impact of toxicity, using the globally 
important, widely-disseminated ST239 lineage (Laabei 
et al. 2014). From our list of 121 statistically significant 
polymorphisms affecting toxicity, we sought to functional 
verify 13 of these loci, resulting in the description of four 
previously uncharacterised regions of the ST239 genome, 
that when disrupted significantly impact on toxicity. Addi-
tionally, by adopting a machine learning approach using 
a subset of these polymorphisms (unique SNPs and one 
SNP from each group of SNPs in linkage disequilibrium) 
we were able to make predictions on the toxicity of these 
strains using sequencing data with high accuracy (>85 %) 
(Laabei et al. 2014).
Staphylococcus aureus gene expression is tightly con-
trolled and has evolved to be energetically efficient. The 
secretion of toxins, generally considered to be positively 
associated with increased disease severity, comes at a high 
energetic price and is readily switched off in vitro (Somer-
ville et al. 2002) with recent observational studies sug-
gesting that this also occurs in vivo (Fowler et al. 2004; 
Rose et al. 2015). In our most recent paper, ‘Evolutionary 
trade-offs underlie the multifaceted virulence of S. aureus’ 
(Laabei et al. 2015), we adopted our functional genomics 
approach to understand and define mutations associated 
with this reduction in toxicity. Therein, we describe the elu-
cidation of six novel loci that when mutated significantly 
decrease toxicity, highlighting the complex nature of S. 
aureus toxin regulation (Laabei et al. 2015). The decrease 
in toxicity was significantly associated with strains origi-
nating from bacteraemia, compared to strains from skin 
and soft tissue infections (SSTIs) or carriage strains. Pre-
vious groups showed that clinical strains isolated from the 
blood had increased defective mutations in the accessory 
gene regulator (Agr) operon, the main quorum sensing sys-
tem which regulates toxins in S. aureus and had increased 
resistance to vancomycin (Sakoulas et al. 2005). Interest-
ingly, in this collection of isolates there was no difference 
in the number of Agr mutations present in the carriage/
SSTI group compared to the bacteraemia group, and no sig-
nificant difference between vancomycin resistance between 
the two groups (data not published).
We further investigated several hypotheses as to why a 
decrease in toxicity may be selected for and associated with 
bacteraemia. By measuring growth dynamics and relative 
fitness, we found that low-toxic isolates were significantly 
more fit when grown in the presence of serum than high-
toxic isolates. Given the extreme bottleneck bacteria have 
to traverse to establish a bloodstream infection, our hypoth-
esis is that a reduction in toxicity by mutation of various 
genes increases its relative fitness compared to high-toxic 
strains due to the energy cost of toxin production.
The discovery and elucidation of novel virulence 
regulators has been an immensely important feature of 
understanding S. aureus pathogenesis. To the best of our 
knowledge there are approximately 30 known virulence 
regulators, including two-component systems, DNA-bind-
ing proteins and regulatory RNAs (Priest et al. 2012; Tuch-
scherr and Loffler 2015). Virulence factors’ expression in S. 
aureus occurs in a temporal growth-phase-dependent man-
ner employing multiple arms of this complex regulon at any 
one time. In the past 2 years, as a result of our functional 
genomics approach a further 10 genetic loci have been 
shown to be affected by S. aureus virulence, specifically 
toxicity. From our unpublished work, we have identified a 
further three loci important in the regulation of toxicity, of 
which we are currently characterising. Following with this 
theme, and focusing on S. aureus biofilm activity, we have 
identified two novel regions that increase biofilm forma-
tion following gene inactivation. These preliminary forays 
into applying functional genomics approaches to microbial 
pathogens clearly illustrate how fruitful this can be.
The functional genomics approach we have developed 
makes use of assaying large numbers of clonally related 
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clinical strains. This methodology has not only allowed us 
to make significant leaps in understanding the vast regulon 
that affects toxicity, and virulence in general, but has high-
lighted that intra-clonally, strains have highly variable tox-
icity levels, a feature that has not been shown to this extent 
before. The functional genomics approach allows us to bet-
ter understand pathogen biology, shown here by the discov-
ery of the trade-off which exists between S. aureus toxicity 
and fitness in serum which we hypothesise is an essential 
step in the progression of bacteraemia. As we are entering 
the next-generation sequencing era, whereby the cost of 
sequencing a single strain has reduced dramatically, whilst 
the accuracy has increased significantly, we desperately 
need a strategy to understand this abundance in genomic 
information and how it impacts on pathogen behaviour. 
By combining large-scale sequencing with comprehensive 
phenotypic studies, we can begin to map the entire viru-
lence pathway, identifying virulence signatures responsible 
for hyper-virulence. These strategies may play a central 
role in developing the holy-grail of patient care, personal-
ised medicine, whereby detailed patient data and bacterial 
genome sequences will be used in combination to optimise 
treatment and improve the outcome for patients.
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